OVERVIEW
The market for organ-on-chips is projected to hit USD 98.3 million by 2025, rising over the forecast period at a CAGR of 34.12%. The growth of this market is mainly driven by a increasing emphasis on developing alternatives for animal testing models, a substantial increase in research funding and venture capital investments for organ-on-chip production, technical developments and new product launches, and a growing number of alliances and collaborations between pharmaceutical companies and chip-on-chip organ manufacturing companies.
TABLE OF CONTENT
1 Global Organs-on-chips Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Organs-on-chips Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Organs-on-chips Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Organs-on-chips Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Organs-on-chips Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Organs-on-chips Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Organs-on-chips Market – By Type (Market Size – & million/billion)
8.1 Liver
8.2 Heart
8.3 Lung
8.4 Kidney
8.5 Other
9 Global Organs-on-chips Market – By Offering
9.1 Products
9.2 Services
10 Global Organs-on-chips Market – By Application
10.1 Physiological Model Development
10.2 Drug Discovery
10.3 Toxicology Research
11 Global Organs-on-chips Market – By End-User
11.1 Pharmaceutical & Biotechnology Companies
11.2 Academic & Research Institutes
11.3 Cosmetics Industry
11.4 Other
12 Global Organs-on-chips Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Organs-on-chips Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Organs-on-chips Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Emulate
14.3 CN Bio
14.4 Tissuse
14.5 Hurel
14.6 Synvivo
14.7 Axosim
14.8 Mimetas
14.9 Insphero
14.10 Ascendance Bio
14.11 Kirkstall
14.12 Company 11 & more
15 Global Organs-on-chips Market – Appendix
15.1 Sources
15.2 Abbreviations
